Infants are among the most susceptible to respiratory complications from respiratory syncytial virus ... antibody in animal ...
The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback